Bank of Montreal
FDMT icon

Bank of Montreal’s 4D Molecular Therapeutics FDMT Stock Holding History

Bank of Montreal’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-21,982
Closed -$122K – 3571
2024
Q4 		$122K Sell
21,982
-31,441
-59% -$247K ﹤0.01% 2899
2024
Q3 		$579K Sell
53,423
-24,831
-32% -$412K ﹤0.01% 2318
2024
Q2 		$1.75M Sell
78,254
-594
-0.8% -$14.9K ﹤0.01% 1725
2024
Q1 		$2.54M Buy
78,848
+53,049
+206% +$1.35M ﹤0.01% 1506
2023
Q4 		$546K Buy
+25,799
New +$339K ﹤0.01% 2435
2021
Q2 		– Sell
-244
Closed -$10K – 4081
2021
Q1 		$10K Buy
+244
New +$10.8K ﹤0.01% 4368

Other funds holding FDMT

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Bank of Montreal's FDMT Position: Q1 2025 in Review

Bank of Montreal sold out of 4D Molecular Therapeutics (FDMT) in Q1 2025, closing a stake of 21,982 shares — an estimated $122K sold.

Bank of Montreal first reported a position in FDMT in Q1 2021 and held it in 6 quarters. The position peaked at $2.54M in Q1 2024. 125 funds tracked by Wall St. Rank hold FDMT as of Q1 2025.

  • Bank of Montreal reported no remaining 4D Molecular Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Bank of Montreal sold 21,982 4D Molecular Therapeutics shares in Q1 2025, an estimated $122K.
  • Bank of Montreal first reported a position in 4D Molecular Therapeutics in Q1 2021 and held it in 6 quarters.
  • Bank of Montreal's 4D Molecular Therapeutics position peaked at $2.54M in Q1 2024.
  • 125 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q1 2025.

Based on Bank of Montreal's 13F filing for Q1 2025, filed 13 May 2025.